큐라넥스(CURX)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.48 (-2.61%), 시가총액 $0.01B, 52주 최저~최고 $0.27 ~ $9.16.
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
큐라넥스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
큐라넥스의 현재 주가는 $4.48 (-2.61%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
큐라넥스의 시가총액은 약 $0.01B입니다.
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops P